19 unknown. 19 Phase 1, 7 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 19 | Unknown 19 |
| Phase 2 | 7 | Unknown 7 |
Follow Schizophrenia: new trials by email Literature Review of Schizophrenia trials Research Report on Schizophrenia
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| The Phase I Study of HS-10509 in Chinese Adult Subjects HS-10509, Placebo - Schizophrenia | Phase 1 | Unknown | Jiangsu Hansoh Pharmaceutical Co., Ltd. | 80 | 2024-03-01 | 2024-03-08 |
| Study on the Bioequivalence of Amisulpride Orally Disintegrating Tablets in Human Body Drug: Test (T) Amisulpride orally disintegrating tablets (200mg). Produced and supplied by Zezheng (Shanghai) Biotechnology Co., Ltd. - Bioequivalence, Schizophrenia | Phase 1 | Unknown | The Affiliated Hospital of Qingdao University | 100 | 2023-09-20 | 2023-10-04 |
| Safety, Tolerability, Pharmacokinetics and Efficacy Study of HS-10380 in Patients With Schizophrenia HS-10380, Placebo - Schizophrenia | Phase 1 / Phase 2 | Unknown | Jiangsu Hansoh Pharmaceutical Co., Ltd. | 112 | 2023-07-30 | 2023-07-28 |
| Minocycline Augmentation of Clozapine for Treatment Resistant Schizophrenia Minocycline - Schizophrenia, Schizoaffective Disorder | Phase 1 | Unknown | Pakistan Institute of Living and Learning | 60 | 2022-08-30 | 2022-04-29 |
| A Study of HS-10380 in Chinese Participants HS-10380, Placebo - Schizophrenia | Phase 1 | Unknown | Jiangsu Hansoh Pharmaceutical Co., Ltd. | 76 | 2022-08-01 | 2023-03-09 |
| Electrical Brain Stimulation for Cognitive Impairment in Schizophrenia: a tDCS-fMRI Study transcranial direct current stimulation - Schizophrenia, Cognitive Impairment | Phase 1 | Unknown | The National Brain Mapping Laboratory (NBML) | 30 | 2022-02-01 | 2023-11-13 |
| Evaluate the Safety, Tolerability and Pharmacokinetic Profile of TPN672 Tablets Maleate in Patients With Schizophrenia TPN-672 - Schizophrenia | Phase 1 | Unknown | Jiangsu Kanion Pharmaceutical Co., Ltd | 62 | 2022-02-01 | 2022-01-14 |
| A Single Ascending Dose Study Of CY150112 After Single Oral Administration in Healthy Chinese Subjects 0.5mg CY150112, 1.5mg CY150112, 4.5mg CY150112 - Schizophrenia | Phase 1 | Unknown | Jiangsu Nhwa Pharmaceutical Co., Ltd. | 60 | 2021-03-02 | 2021-04-09 |
| A Safety，Tolerability and Pharmacokinetics Clinical Trial of JX11502MA Capsule JX11502MA, Placebo - Schizophrenia | Phase 1 | Unknown | Zhejiang Jingxin Pharmaceutical Co., Ltd. | 58 | 2020-01-04 | 2022-02-10 |
| Pentoxifylline Add-on Therapy for Schizophrenia Oxopurin - Schizophrenia | Phase 1 / Phase 2 | Unknown | Mazra Mental Health Center | 90 | 2019-04-20 | 2021-10-11 |
| Touchscreen-based Cognitive Tests in Healthy Volunteers Ketamine 0.58, Ketamine 0.31, Modafinil - Cognitive Symptom, Schizophrenia | Phase 1 | Unknown | University of Eastern Finland | 16 | 2018-03-12 | 2018-10-16 |
| Tocilizumab in Schizophrenia Tocilizumab, Normal saline - Schizophrenia, Psychotic Disorders | Phase 1 | Unknown | Brian Miller | 20 | 2016-09-01 | 2023-07-21 |
| Siltuximab in Schizophrenia Siltuximab, normal saline - Schizophrenia, Psychotic Disorders | Phase 1 / Phase 2 | Unknown | Brian Miller | 30 | 2016-05-01 | 2023-07-21 |
| Pilot Study Using an NMDA Antagonist to Modulate Transcranial Direct Current Stimulation (tDCS) Effects on Sensory Discrimination Direct Current Stimulation, Dextromethorphan - Schizophrenia | Phase 1 / Phase 2 | Unknown | University of Ottawa | 12 | 2015-04-01 | 2015-04-27 |
| The Role of miR-30 Family Dysregulation in Response to Antipsychotic Treatment Risperidone, Olanzapine, Quetiapine - Schizophrenia | Phase 1 / Phase 2 | Unknown | Shanxi Medical University | 200 | 2013-01-01 | 2016-01-08 |
| Supervised Treatment of Schizophrenia, a Randomized Controlled Trial. Supervised Treatment of Schizophrenia by a family member - Schizophrenia, Schizoaffective Disorders | Phase 1 / Phase 2 | Unknown | Lady Reading Hospital, Pakistan | 110 | 2006-11-01 | 2008-02-27 |
| Reboxetine Adjuvant Therapy for the Treatment of Schizophrenia reboxetine adjuvant therapy - Schizophrenia | Phase 1 | Unknown | Abarbanel Mental Health Center | 30 | 2006-03-01 | 2006-12-08 |
| Families Coping With Mental Illness Program Psychoeducation - Schizophrenia, Schizoaffective Disorder | Phase 1 | Unknown | North Suffolk Mental Health Association | 50 | 2002-06-01 | 2007-02-15 |
| D-Serine Monotherapy for Schizophrenia D-serine 2100 mg daily - Schizophrenia | Phase 1 / Phase 2 | Unknown | Herzog Hospital | 40 | 2006-05-03 |
Psychotic Disorders (5) · Inflammation (2) · Behavior (1) · Cognitive Dysfunction (1) · Medication Adherence (1) · Mental Disorders (1) · Neurobehavioral Manifestations (1) · cyclopia sequence (1)
Schizophrenia Spectrum and Other Psychotic Disorders (19) · Mental Disorders (18) · Pathological Conditions, Signs and Symptoms (3) · Pathologic Processes (2) · Behavior (1) · Cognition Disorders (1) · Health Behavior (1) · Nervous System Diseases (1) · Neurocognitive Disorders (1) · Neurologic Manifestations (1) · Patient Acceptance of Health Care (1) · Patient Compliance (1) · Signs and Symptoms (1) · Treatment Adherence and Compliance (1)
Saline Solution (2) · Transcranial Direct Current Stimulation (2) · Amisulpride (1) · Aripiprazole (1) · Dextromethorphan (1) · Drug Evaluation (1) · Ketamine (1) · Long-Term Synaptic Depression (1) · Minocycline (1) · Modafinil (1) · Olanzapine (1) · Pentoxifylline (1) · Quetiapine Fumarate (1) · Risperidone (1) · siltuximab (1)
Jiangsu Hansoh Pharmaceutical Co., Ltd. (3) · Brian Miller (2) · Abarbanel Mental Health Center (1) · Herzog Hospital (1) · Jiangsu Kanion Pharmaceutical Co., Ltd (1) · Jiangsu Nhwa Pharmaceutical Co., Ltd. (1) · Lady Reading Hospital, Pakistan (1) · Mazra Mental Health Center (1) · North Suffolk Mental Health Association (1) · Pakistan Institute of Living and Learning (1) · Shanxi Medical University (1) · The Affiliated Hospital of Qingdao University (1) · The National Brain Mapping Laboratory (NBML) (1) · University of Eastern Finland (1) · University of Ottawa (1)
China (7) · Israel (3) · United States (3) · Pakistan (2) · Canada (1) · Finland (1) · Iran (1)
Brian J Miller, MD (1) · Danielle Impey, Ph.D. (cand.) (1) · Dr.Inti Qurashi, MD (1) · Li Guanjun (1) · Li Huafang, MD PhD (1) · Markus M Forsberg, PhD (1) · Michelle S. Friedman-Yakoobian, Ph.D. (1) · Pesach Lichtenberg, M.D. (1) · Saeed Farooq, MCPS,FCPS (1) · Xiaojiao Li, Dr. (1) · Yong Xu, Doctor (1)
2017 (1)